Cite
HARVARD Citation
Szeglin, B. et al. (2022). A SMAD4‐modulated gene profile predicts disease‐free survival in stage II and III colorectal cancer. Cancer reports. 5 (1), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Szeglin, B. et al. (2022). A SMAD4‐modulated gene profile predicts disease‐free survival in stage II and III colorectal cancer. Cancer reports. 5 (1), p. n/a. [Online].